BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Sanwa Kagaku Kenkyusho., Ltd. (SKK) 

35 Higashisotobori-cho

Higashi-ku  Nagoya  461-8631  Japan
Phone: 81-52-951-8130 Fax: 81-52-957-1066


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Catalent Pharma Solutions and Sanwa Kagaku Kenkyusho., Ltd. (SKK) Announce Exclusive License For OSDrC(R) Technology, Bringing New Modified Release Delivery Technology to the Rx and OTC Global Market 7/14/2011 10:14:07 AM
Shanghai ChemPartner Co., Ltd. and Sanwa Kagaku Kenkyusho., Ltd. (SKK) Announce Strategic Alliance 4/20/2009 10:45:36 AM
VistaGen Therapeutics, Inc. Licenses Customized Stem Cell-Based Drug Discovery Assays to Sanwa Kagaku Kenkyusho, a Japanese Pharmaceutical Company 5/22/2008 10:08:17 AM
VistaGen Therapeutics, Inc. And Sanwa Kagaku Kenkyusho Renew Embryonic Stem Cell Drug Discovery And Development Partnership Focused On New Diabetes Treatments 11/30/2006 11:05:59 AM
4SC AG Enters Next Phase Of Drug Discovery Collaboration With Sanwa Kagaku Kenkyusho 1/17/2006 10:29:18 AM
Sanwa Kagaku Kenkyusho Releases SEIBULE, Miglitol Agent For Controlling Postprandical Blood Glucose 1/11/2006 1:26:05 PM
Allergan Inc. (AGN) And Sanwa Kagaku Kenkyusho Sign Exclusive Licensing Agreement To Develop And Market POSURDEX(R) In Japan10/19/2005 5:13:07 PM
4SC AG And Sanwa Kagaku Kenkyusho Enter Into Multi-Year Drug Discovery Collaboration10/19/2005 5:12:44 PM
Sanwa Kagaku Kenkyusho And Quark Biotech, Inc. Enter Collaboration To License Dyslipidemia Therapy10/19/2005 5:12:39 PM
VistaGen Therapeutics, Inc. And Sanwa Kagaku Kenkyusho Announce First Embryonic Stem Cell Research Partnership Focused On New Treatments For Diabetes 10/19/2005 5:11:49 PM
12